NCT00001911View on ClinicalTrials.gov

Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

July 31, 2003

Conditions
Atypical Mycobacterium Infection
Interventions
DRUG

Interleukin-12

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001911 - Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections | Biotech Hunter | Biotech Hunter